Publication | Open Access
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
257
Citations
11
References
2021
Year
Invasive AspergillosisPosaconazole Versus VoriconazoleAntifungal AgentAntifungal AgentsMedicinal FungiMedicineFungal PathogenPhase 3
| Year | Citations | |
|---|---|---|
Page 1
Page 1